PCa generally exhibits a “cold” immune microenvironment, with low basal CD8+ T-cell infiltration in many settings, however, both the density and functional competence of these T cells can be reshaped by tumor stage, antigen specificity, and therapeutic interventions. The gene discussed is CD8A; the disease is neoplasm.